Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized (Q31089499)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized |
scientific article |
Statements
1 reference
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized (English)
1 reference
Kelly K Hunt
1 reference
Gabriel N Hortobagyi
1 reference
Sonja E Singletary
1 reference
Aman U Buzdar
1 reference
Vicente Valero
1 reference
Nuhad K Ibrahim
1 reference
Deborah Francis
1 reference
Kristine R Broglio
1 reference
Richard L Theriault
1 reference
Lajos Pusztai
1 reference
Marjorie C Green
1 reference
Aysegul A Sahin
1 reference
Francisco Esteva
1 reference
William F Symmans
1 reference
Michael S Ewer
1 reference
Thomas A Buchholz
1 reference
1 January 2007
1 reference
1 reference
Identifiers
1 reference